Last updated on: 9/4/2007 | Author:

Canadian Consortium for the Investigation of Cannabinoids in Human Therapeutics (CCIC) Biography

Not Clearly Pro or Con to the question "Should Marijuana Be a Medical Option?"

“The participants of the CCIC agreed to fully endorse the recommendations of previous national and international medical and government bodies regarding the research and therapeutic use of cannabinoids. These include the World Health Organization, the British Medical Association, the National Academy of Science Institute of Medicine (USA), The British House of Lords, a Committee of the New Zealand Parliament, and the Therapeutic Products Program of Health Canada.

In summary all of these reports acknowledged the need for further research regarding cannabinoids, all recommended research regarding alternate methods of delivery, and all accept that anti-nausea, appetite stimulation, analgesia and anti-spasticity applications are worthy of further research.”



“The CCIC is a national interdisciplinary research consortium that came together in the Spring of 2000 as a result of initial funding from the CIHR. Researchers from basic and clinical sciences from Newfoundland to British Columbia are a part of the CCIC. The CCIC will facilitate both basic science and clinical trials examining cannabinoids as therapeutic agents. The CCIC is currently developing a national clinical trials network.”

“Background,” CCIC website (accessed Sep. 4, 2007)


“The mission of the CCIC is to bring together key Canadian researchers who will pursue excellence in basic science and clinical research on the cannabinoids system. The CCIC will liaise with members of Health Canada, CIHR (Canadian Institutes of Health Research) and other bodies in order to facilitate cannabinoid research across the country.”

“Background,” CCIC website (accessed Sep. 4, 2007)

Research organization